Showing 1 - 7 results of 7 for search 'György Vereb', query time: 0.05s Refine Results
  1. 1
    Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC

    Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated... by Lőrinc Nagy, Marianna Mezősi-Csaplár, István Rebenku, György Vereb, György Vereb, György Vereb, Árpád Szöőr

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio

    Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio by István Rebenku, Cameron B. Lloyd, János Szöllősi, György Vereb

    Published 2023-02-01
    Get full text
    Article
  3. 3
    CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation

    CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation by Markus Barden, Astrid Holzinger, Lukas Velas, Marianna Mezősi-Csaplár, Árpád Szöőr, György Vereb, György Vereb, Gerhard J. Schütz, Andreas A. Hombach, Andreas A. Hombach, Hinrich Abken

    Published 2023-02-01
    Get full text
    Article
  4. 4
    Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia

    Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia by Gergely Losonczy, Nurit Rosenberg, Zoltán Boda, György Vereb, János Kappelmayer, Hagit Hauschner, Zsuzsanna Bereczky, László Muszbek

    Published 2007-05-01
    Get full text
    Article
  5. 5
    Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan

    Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan by Negar Pourjamal, Vadim Le Joncour, György Vereb, Cilla Honkamaki, Jorma Isola, Jeffrey V Leyton, Pirjo Laakkonen, Heikki Joensuu, Mark Barok

    Published 2025-03-01
    Get full text
    Article
  6. 6
    Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy

    Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy by Arpad Szoor, Gyorgy Vereb, Orit Itzhaki, Michal J Besser, Hinrich Abken, Dayana Blokon-Kogan, Maya Levi-Mann, Lior Malka-Levy, Yuval Shiftan, Gideon Gross, Hadas Weinstein-Marom

    Published 2022-09-01
    Get full text
    Article
  7. 7
    Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function

    Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function by Arpad Szoor, Gyorgy Vereb, Hinrich Abken, Markus Barden, Patrick Ronan Elsenbroich, Vivian Haas, Moritz Ertelt, Philip Pervan, Lukas Velas, Bence Gergely, Dennis Christoph Harrer, Valerie Bezler, Astrid Holzinger, Rasmus Ulslev Wegener Friis, Gerhard J Schütz, Clara T Schoeder, Andreas A Hombach

    Published 2024-12-01
    Get full text
    Article

Search Tools: